- Raised $8M funding round, Aug 2018
- Raised $2.3M grant, Oct 2020
- Raised $650k funding round, Mar 2016
About
MyBiotics Pharma is a microbiome company focused on bettering peoples lives and health by greatly improving on existing probiotic solutions. MyBiotics has developed a novel technological platform for the development of microbiome-related drugs and supplements. The companys platform uses innovative formulation, delivery, and culturing methods designed to provide better viability and resistance, and potentially improved colonization and clinical results. Based on this proprietary innovation, MyBiotics has developed three main technologies: MyCrobe, SuperDonor, and Super Donor Select, which are all supported by MyLiveIn, a computational and AI technology platform. After targeting specific medical indications, MyBiotics has now reached the clinical stage with three products. Based on the companys SuperDonor technology, its MBX-SD-201 and MBX-SD-202 products offer safe and reproducible microbiome restoration and may become an alternative for complete microbiome recovery and design using fecal microbiota transplantation. MyBiotics has initiated significant collaborations and development agreements with a variety of pharmaceutical companies and clinical partners in the areas of C. diff, oncology, dermatology, and womens health.
Funding history · 5 rounds · $11.3M total
Q&A
- What is MyBiotics Pharma's primary focus?
- MyBiotics Pharma is a microbiome company dedicated to improving health through enhanced probiotic solutions and has developed a novel technological platform for microbiome-related drugs and supplements.
- When was MyBiotics Pharma founded?
- MyBiotics Pharma was founded in July 2014.
- How many employees does MyBiotics Pharma have?
- MyBiotics Pharma has 11-50 employees.
- What is MyBiotics Pharma's total funding to date?
- MyBiotics Pharma has raised a total of $11.27 million USD.
- Which technologies has MyBiotics Pharma developed?
- MyBiotics Pharma has developed three main technologies: MyCrobe, SuperDonor, and Super Donor Select, all supported by MyLiveIn, a computational and AI technology platform.
- In which medical areas has MyBiotics Pharma initiated collaborations?
- MyBiotics Pharma has initiated collaborations and development agreements in the areas of C. diff, oncology, dermatology, and women's health.
- What is the current product stage for MyBiotics Pharma?
- MyBiotics Pharma's products are currently in the clinical trial stage, with three products having reached this stage.
- Who is the Co-founder and CEO of MyBiotics Pharma?
- Didi Daboush is the Co-founder and CEO of MyBiotics Pharma.
- Has MyBiotics Pharma received any grants?
- Yes, in October 2020, MyBiotics Pharma received a grant of $2.3 million USD from EU Horizon 2020.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | mybiotics-pharma.com/ |
|---|---|
| linkedin.com/company/6381842 | |
| YouTube | youtube.com/channel/UCHyT6ZnVW9WRjfpx2On7-Tw |
Identifiers & details
| Former names | MyBiotix Pharma |
|---|---|
| Founded | 2014-7 |
| Employees (exact) | 13 |
Radar intelligence
Patents
| EPO | 9 |
|---|
Web history (Wayback)
| Domain | mybiotics-pharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|